Phospholipid biosynthesis, ethanolamine-phosphate cytidylyltransferase
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005829 | cytosol | 2 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3S7X5B3
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 12 |
GO:0006644 | phospholipid metabolic process | 4 | 12 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 6 | 12 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 12 |
GO:0006793 | phosphorus metabolic process | 3 | 12 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0008610 | lipid biosynthetic process | 4 | 12 |
GO:0008654 | phospholipid biosynthetic process | 5 | 12 |
GO:0009058 | biosynthetic process | 2 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0019637 | organophosphate metabolic process | 3 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044249 | cellular biosynthetic process | 3 | 12 |
GO:0044255 | cellular lipid metabolic process | 3 | 12 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 12 |
GO:0046337 | phosphatidylethanolamine metabolic process | 6 | 12 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 12 |
GO:0046486 | glycerolipid metabolic process | 4 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090407 | organophosphate biosynthetic process | 4 | 12 |
GO:1901576 | organic substance biosynthetic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity | 6 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 12 |
GO:0016779 | nucleotidyltransferase activity | 4 | 12 |
GO:0070567 | cytidylyltransferase activity | 5 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 156 | 160 | PF00656 | 0.417 |
CLV_C14_Caspase3-7 | 311 | 315 | PF00656 | 0.555 |
CLV_NRD_NRD_1 | 215 | 217 | PF00675 | 0.403 |
CLV_NRD_NRD_1 | 74 | 76 | PF00675 | 0.308 |
CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.206 |
CLV_PCSK_KEX2_1 | 375 | 377 | PF00082 | 0.410 |
CLV_PCSK_KEX2_1 | 74 | 76 | PF00082 | 0.308 |
CLV_PCSK_PC1ET2_1 | 167 | 169 | PF00082 | 0.217 |
CLV_PCSK_PC1ET2_1 | 375 | 377 | PF00082 | 0.461 |
CLV_PCSK_SKI1_1 | 164 | 168 | PF00082 | 0.225 |
CLV_PCSK_SKI1_1 | 180 | 184 | PF00082 | 0.405 |
CLV_PCSK_SKI1_1 | 370 | 374 | PF00082 | 0.396 |
CLV_PCSK_SKI1_1 | 380 | 384 | PF00082 | 0.523 |
CLV_Separin_Metazoa | 89 | 93 | PF03568 | 0.510 |
DEG_SCF_TRCP1_1 | 352 | 358 | PF00400 | 0.357 |
DEG_SPOP_SBC_1 | 4 | 8 | PF00917 | 0.673 |
DOC_ANK_TNKS_1 | 51 | 58 | PF00023 | 0.271 |
DOC_CYCLIN_RxL_1 | 177 | 185 | PF00134 | 0.330 |
DOC_CYCLIN_yClb1_LxF_4 | 368 | 373 | PF00134 | 0.427 |
DOC_MAPK_gen_1 | 126 | 135 | PF00069 | 0.420 |
DOC_MAPK_gen_1 | 275 | 284 | PF00069 | 0.473 |
DOC_MAPK_gen_1 | 338 | 347 | PF00069 | 0.284 |
DOC_MAPK_gen_1 | 74 | 82 | PF00069 | 0.508 |
DOC_MAPK_MEF2A_6 | 46 | 55 | PF00069 | 0.300 |
DOC_PP1_RVXF_1 | 215 | 222 | PF00149 | 0.439 |
DOC_PP1_RVXF_1 | 368 | 374 | PF00149 | 0.452 |
DOC_PP4_FxxP_1 | 93 | 96 | PF00568 | 0.510 |
DOC_WW_Pin1_4 | 203 | 208 | PF00397 | 0.570 |
DOC_WW_Pin1_4 | 223 | 228 | PF00397 | 0.340 |
DOC_WW_Pin1_4 | 5 | 10 | PF00397 | 0.626 |
LIG_14-3-3_CanoR_1 | 151 | 155 | PF00244 | 0.436 |
LIG_Actin_WH2_2 | 175 | 193 | PF00022 | 0.543 |
LIG_Actin_WH2_2 | 55 | 73 | PF00022 | 0.417 |
LIG_APCC_ABBA_1 | 345 | 350 | PF00400 | 0.425 |
LIG_BRCT_BRCA1_1 | 199 | 203 | PF00533 | 0.489 |
LIG_FHA_1 | 167 | 173 | PF00498 | 0.441 |
LIG_FHA_1 | 357 | 363 | PF00498 | 0.322 |
LIG_FHA_1 | 38 | 44 | PF00498 | 0.370 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.258 |
LIG_Integrin_isoDGR_2 | 149 | 151 | PF01839 | 0.214 |
LIG_LIR_Apic_2 | 336 | 342 | PF02991 | 0.343 |
LIG_LIR_Gen_1 | 102 | 110 | PF02991 | 0.431 |
LIG_LIR_Gen_1 | 153 | 160 | PF02991 | 0.406 |
LIG_LIR_Gen_1 | 237 | 248 | PF02991 | 0.406 |
LIG_LIR_Gen_1 | 33 | 43 | PF02991 | 0.384 |
LIG_LIR_Gen_1 | 56 | 67 | PF02991 | 0.417 |
LIG_LIR_LC3C_4 | 327 | 331 | PF02991 | 0.398 |
LIG_LIR_Nem_3 | 102 | 108 | PF02991 | 0.406 |
LIG_LIR_Nem_3 | 153 | 157 | PF02991 | 0.406 |
LIG_LIR_Nem_3 | 237 | 243 | PF02991 | 0.406 |
LIG_LIR_Nem_3 | 33 | 38 | PF02991 | 0.329 |
LIG_LIR_Nem_3 | 393 | 398 | PF02991 | 0.505 |
LIG_LIR_Nem_3 | 56 | 62 | PF02991 | 0.417 |
LIG_LYPXL_yS_3 | 279 | 282 | PF13949 | 0.473 |
LIG_OCRL_FandH_1 | 58 | 70 | PF00620 | 0.406 |
LIG_PCNA_yPIPBox_3 | 285 | 295 | PF02747 | 0.417 |
LIG_PTB_Apo_2 | 117 | 124 | PF02174 | 0.449 |
LIG_PTB_Phospho_1 | 117 | 123 | PF10480 | 0.449 |
LIG_Rb_LxCxE_1 | 33 | 50 | PF01857 | 0.390 |
LIG_SH2_CRK | 339 | 343 | PF00017 | 0.263 |
LIG_SH2_CRK | 395 | 399 | PF00017 | 0.434 |
LIG_SH2_SRC | 154 | 157 | PF00017 | 0.417 |
LIG_SH2_SRC | 235 | 238 | PF00017 | 0.406 |
LIG_SH2_SRC | 260 | 263 | PF00017 | 0.406 |
LIG_SH2_STAP1 | 266 | 270 | PF00017 | 0.510 |
LIG_SH2_STAT3 | 266 | 269 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 116 | 119 | PF00017 | 0.420 |
LIG_SH2_STAT5 | 123 | 126 | PF00017 | 0.394 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.406 |
LIG_SH2_STAT5 | 235 | 238 | PF00017 | 0.406 |
LIG_SH2_STAT5 | 260 | 263 | PF00017 | 0.406 |
LIG_SH2_STAT5 | 296 | 299 | PF00017 | 0.406 |
LIG_SH3_3 | 14 | 20 | PF00018 | 0.524 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.407 |
LIG_TRAF2_1 | 153 | 156 | PF00917 | 0.417 |
LIG_TRAF2_1 | 86 | 89 | PF00917 | 0.431 |
MOD_CDK_SPK_2 | 223 | 228 | PF00069 | 0.460 |
MOD_CK1_1 | 222 | 228 | PF00069 | 0.521 |
MOD_CK1_1 | 353 | 359 | PF00069 | 0.355 |
MOD_CK1_1 | 7 | 13 | PF00069 | 0.690 |
MOD_CK2_1 | 150 | 156 | PF00069 | 0.444 |
MOD_CK2_1 | 189 | 195 | PF00069 | 0.542 |
MOD_CK2_1 | 198 | 204 | PF00069 | 0.541 |
MOD_CK2_1 | 83 | 89 | PF00069 | 0.406 |
MOD_GlcNHglycan | 12 | 15 | PF01048 | 0.681 |
MOD_GlcNHglycan | 228 | 231 | PF01048 | 0.446 |
MOD_GlcNHglycan | 352 | 355 | PF01048 | 0.384 |
MOD_GSK3_1 | 166 | 173 | PF00069 | 0.432 |
MOD_GSK3_1 | 219 | 226 | PF00069 | 0.439 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.645 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.452 |
MOD_N-GLC_1 | 222 | 227 | PF02516 | 0.420 |
MOD_NEK2_1 | 182 | 187 | PF00069 | 0.497 |
MOD_NEK2_1 | 198 | 203 | PF00069 | 0.476 |
MOD_NEK2_1 | 212 | 217 | PF00069 | 0.322 |
MOD_NEK2_2 | 290 | 295 | PF00069 | 0.417 |
MOD_PIKK_1 | 384 | 390 | PF00454 | 0.508 |
MOD_PKA_2 | 150 | 156 | PF00069 | 0.402 |
MOD_Plk_1 | 142 | 148 | PF00069 | 0.406 |
MOD_Plk_1 | 198 | 204 | PF00069 | 0.571 |
MOD_Plk_1 | 33 | 39 | PF00069 | 0.307 |
MOD_Plk_2-3 | 142 | 148 | PF00069 | 0.417 |
MOD_Plk_4 | 198 | 204 | PF00069 | 0.615 |
MOD_Plk_4 | 33 | 39 | PF00069 | 0.435 |
MOD_Plk_4 | 358 | 364 | PF00069 | 0.457 |
MOD_ProDKin_1 | 203 | 209 | PF00069 | 0.567 |
MOD_ProDKin_1 | 223 | 229 | PF00069 | 0.343 |
MOD_ProDKin_1 | 5 | 11 | PF00069 | 0.626 |
MOD_SUMO_rev_2 | 379 | 387 | PF00179 | 0.483 |
TRG_ENDOCYTIC_2 | 105 | 108 | PF00928 | 0.406 |
TRG_ENDOCYTIC_2 | 154 | 157 | PF00928 | 0.424 |
TRG_ENDOCYTIC_2 | 279 | 282 | PF00928 | 0.492 |
TRG_ENDOCYTIC_2 | 348 | 351 | PF00928 | 0.413 |
TRG_ENDOCYTIC_2 | 35 | 38 | PF00928 | 0.393 |
TRG_ENDOCYTIC_2 | 395 | 398 | PF00928 | 0.499 |
TRG_ER_diArg_1 | 74 | 76 | PF00400 | 0.507 |
TRG_Pf-PMV_PEXEL_1 | 216 | 220 | PF00026 | 0.351 |
TRG_Pf-PMV_PEXEL_1 | 255 | 259 | PF00026 | 0.279 |
TRG_Pf-PMV_PEXEL_1 | 74 | 78 | PF00026 | 0.310 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P9A3 | Leptomonas seymouri | 82% | 100% |
A0A0S4KIJ8 | Bodo saltans | 69% | 96% |
A0A1X0NUM2 | Trypanosomatidae | 71% | 100% |
A0A422N8Y0 | Trypanosoma rangeli | 69% | 100% |
A4HK70 | Leishmania braziliensis | 88% | 100% |
A4I7Q5 | Leishmania infantum | 100% | 100% |
A9N9S2 | Coxiella burnetii (strain RSA 331 / Henzerling II) | 25% | 85% |
D0A9W0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 61% | 100% |
E9B2L3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
O88637 | Rattus norvegicus | 44% | 100% |
P33412 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 37% | 100% |
Q4Q5J3 | Leishmania major | 94% | 100% |
Q55BZ4 | Dictyostelium discoideum | 54% | 100% |
Q5EA75 | Bos taurus | 46% | 100% |
Q83B60 | Coxiella burnetii (strain RSA 493 / Nine Mile phase I) | 25% | 85% |
Q8SQW6 | Encephalitozoon cuniculi (strain GB-M1) | 35% | 100% |
Q922E4 | Mus musculus | 44% | 100% |
Q99447 | Homo sapiens | 46% | 100% |
Q9UTI6 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 37% | 100% |
Q9ZVI9 | Arabidopsis thaliana | 46% | 95% |
V5DHH9 | Trypanosoma cruzi | 67% | 100% |